|
Methyl Alcohol
(meth' il al' ka hol).
DEFINITION
Methyl Alcohol contains NLT 99.5% of CH3OH.
[CautionMethyl Alcohol is poisonous.
]
IDENTIFICATION
• B.
The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
ASSAY
• Procedure
System suitability solution:
Dilute 1.0 mL of USP Methyl Alcohol RS and 1.0 mL of USP Acetone RS with tetrahydrofuran to 50 mL.
Internal standard solution:
2% (v/v) acetonitrile in tetrahydrofuran
Standard solution:
15.8 mg/mL of USP Methyl Alcohol RS in Internal standard solution
Sample solution:
15.8 mg/mL of Methyl Alcohol in Internal standard solution
Chromatographic system
Detector:
Flame ionization
Column:
0.32-mm × 30-m fused-silica capillary column, coated with a 1.8-µm layer of phase G43
Temperature
Injector:
200
Detector:
280
Column:
See Table 1.
Table 1
Carrier gas:
Helium
Linear velocity:
35 cm/s
Injection type:
Split ratio, 20:1
Injection size:
1 µL
System suitability
Samples:
System suitability solution and Standard solution
[NoteThe relative retention times for methyl alcohol, acetone, and acetonitrile are 1.0, about 1.6, and about 1.8, respectively. ]
Suitability requirements
Resolution:
NLT 15 between methyl alcohol and acetone, System suitability solution
Tailing factor:
NLT 1.5 for methyl alcohol, System suitability solution
Relative standard deviation:
NMT 2.0% for the ratio of the peak area of methyl alcohol to acetonitrile, Standard solution
Analysis
Samples:
Standard solution and Sample solution
Calculate the percentage of methyl alcohol (CH3OH) in the portion of Methyl Alcohol taken:
Result = (RU/RS) × (CS/CU) × 100
Acceptance criteria:
NLT 99.5%
IMPURITIES
• Nonvolatile Residue
Sample:
250 mL of Methyl Alcohol
Analysis:
Evaporate the Sample in a 600-mL beaker on a steam bath, in a well-ventilated hood, until the volume is reduced to about 100 mL. Cool, transfer a portion of the liquid to a suitable, tared 50-mL platinum dish on a steam bath, and evaporate. Repeat the process until all of the liquid has been transferred, and then evaporate to dryness. Dry at 105
Acceptance criteria:
The weight of the residue does not exceed 2 mg, corresponding to NMT 0.001% (w/w).
• Acetone and Aldehydes (as acetone)
Standard solution:
Dilute 1.9 mL (1.5 g) of acetone with water to 1000 mL, then dilute 1.0 mL of this solution with water to 100 mL. Dilute 2 mL of the resulting solution with water to 5 mL. The Standard solution contains 30 µg of acetone and is freshly prepared.
Sample solution:
Dilute 1.25 mL (1 g) of Methyl Alcohol with water to 5 mL.
Analysis:
Adjust to and maintain each solution at 20
Acceptance criteria:
Any turbidity produced in the Sample solution is not greater than that produced in the Standard solution (NMT 0.003%).
• Readily Carbonizable Substances
Sample:
5 mL
Analysis:
Cool 5 mL of sulfuric acid, contained in a small conical flask, to 10
Acceptance criteria:
No discoloration develops.
• Readily Oxidizable Substances
Sample:
20 mL of Methyl Alcohol
Analysis:
Cool the Sample to 15
Acceptance criteria:
The pink color does not completely disappear within 5 min.
SPECIFIC TESTS
• Acidity
Sample solution:
Mix 25 mL of water with 10 mL of alcohol and 0.5 mL of phenolphthalein TS, and add 0.02 N sodium hydroxide until a slight pink color persists after shaking for 30 s. Taking precautions to avoid absorption of carbon dioxide, add 19 mL (15 g) of Methyl Alcohol.
Analysis:
Titrate the Sample solution with 0.020 N sodium hydroxide.
Acceptance criteria:
NMT 0.45 mL of 0.020 N sodium hydroxide is required to produce a pink color.
• Alkalinity (as ammonia)
Sample:
28.6 mL (22.6 g) of Methyl Alcohol
Analysis:
Mix the Sample with 25 mL of water, add 1 drop of methyl red TS, and titrate with 0.020 N sulfuric acid.
Acceptance criteria:
NMT 0.20 mL of 0.020 N sulfuric acid is required to produce a pink color (3 ppm).
• Water Determination, Method I
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in tight containers, remote from heat, sparks, and open flames.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 1865
Pharmacopeial Forum: Volume No. 34(5) Page 1226
|